Gearbox Biosciences

unknown
unknown
Stage
1
Investors

About

Gearbox Biosciences develops an antibiotic-free platform (Pop-Out-Plasmid™) for producing plasmid DNA and recombinant proteins in engineered E. coli by integrating genes into the chromosome and triggering temperature-dependent excision and amplification to generate high-copy, selection-free plasmids and high-yield protein expression without antibiotics or chemical inducers.

Explore Gearbox Biosciences's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.